Zonisamide (Exelan Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Zonisamide drug offered from Exelan Pharmaceuticals, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Exelan Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Zonisamide |
| SUBSTANCE NAME: | ZONISAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-07-05 |
| END MARKETING DATE: | 0000-00-00 |
Zonisamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zonisamide from Exelan Pharmaceuticals, Inc. |
| LABELER NAME: | Exelan Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2006-07-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76282-228_24284954-0c29-458f-a9f8-97a7ad418ca7 |
| PRODUCT NDC: | 76282-228 |
| APPLICATION NUMBER: | ANDA077869 |
Other ZONISAMIDE Pharmaceutical Manufacturers / Labelers:
